Translational Medicine Academy

Startseite
Schweiz
Basel
Translational Medicine Academy

BRIDGING THE GAPS BETWEEN KNOWLEDGE AND CARE – FASTER

TMA is a nonprofit advancing science to care.

We connect experts to speed clinical adoption and move innovation from lab to bedside through collaboration and translational research.

23/06/2026

Obesity and HFpEF continue to be closely examined within the broader cardiometabolic spectrum, where overlapping mechanisms challenge traditional disease boundaries.

At e-SPACE Heart Failure 2025, Prof. Muthiah Vaduganathan and Prof. Gianluigi Savarese discussed this relationship through the lens of evolving heart failure phenotypes and their clinical implications.

That discussion remains relevant as the field progresses toward more integrated approaches in e-SPACE Heart Failure 2026.

23–24 October 2026 | Online
https://tinyurl.com/3vb4mys5

19/06/2026

MASH continues to sit at the intersection of metabolic, hepatic, and cardiovascular disease, where progression is driven not by a single pathway, but by overlapping risk mechanisms that demand integrated thinking.

MOSAIC MASH 2026 is built around this shift, bringing together clinical perspectives and emerging evidence to better understand how care pathways are evolving across disciplines and what that means for real-world practice.

Join the conversation and be part of shaping the future of integrated care at MOSAIC MASH 2026.

26-27 October 2026 | Washington, D.C.
Save the Date: https://mosaic-nash.tmacademy.org/

17/06/2026

TMA was pleased to participate in ADA 2026, where discussions across obesity, diabetes, metabolic health, and body composition reinforced the need for a more integrated CKLM (Cardiovascular–Kidney–Liver–Metabolic) approach to patient care.

The insights shared throughout the meeting reflected many of the themes that underpin TMA's educational mission: connecting disciplines, translating emerging evidence into practice, and supporting clinicians in managing increasingly interconnected conditions.

These conversations will continue throughout TMA's 2026 educational programme, including:
- AF Screen Meeting 2026
- TMA Symposia at ESC Congress 2026
- Heart Failure & Cardio-Renal-Metabolic Guidelines Forum 2026
- e-SPACE Heart Failure 2026
- MOSAIC-MASH Forum 2026
- Updates in Heart Failure 2026

We look forward to building on the momentum from ADA 2026 and continuing to bring together experts, data, and disciplines to advance care across the CKLM continuum.

16/06/2026

Despite strong evidence supporting guideline-directed medical therapy, its translation into routine heart failure care remains inconsistent, shaped by practical barriers in initiation, titration, and long-term adherence.

Early in-hospital initiation of GDMT represents a critical opportunity to influence outcomes, yet its implementation continues to vary across clinical settings, highlighting the need for more structured, system-supported approaches alongside clinician-driven action.

e-SPACE Heart Failure 2026 continues this focus on bridging the implementation gap, with discussions centred on how evidence can be more effectively translated into everyday practice: https://tinyurl.com/3vb4mys5

16/06/2026

How are recent ASCO 2026 updates reshaping the treatment landscape in metastatic breast cancer?

Are we entering a new era where antibody-drug conjugates, immunotherapy combinations, and biomarker-driven strategies are redefining sequencing decisions in HER2-positive and triple-negative disease?

This focused live session explores how advances in metastatic breast cancer are being translated into clinical practice, alongside the real-world challenges of toxicity management, access to novel therapies, and optimizing outcomes across diverse healthcare settings.
Join global perspectives discussing how emerging evidence is influencing treatment decisions in advanced disease.

Register Now: https://www.p2pmd.net/post-asco26-bc2

11/06/2026

Global Fatty Liver Day brings attention to the growing clinical significance of metabolic dysfunction-associated steatohepatitis (MASH) within the broader cardiometabolic disease spectrum.

As understanding evolves beyond isolated liver pathology, the need for integrated, multidisciplinary approaches becomes increasingly central to both research and clinical practice.

MOSAIC MASH 2026 reflects this direction, bringing together diverse scientific perspectives to advance discussion on evidence, disease complexity, and emerging pathways in MASH.

26–27 October 2026 | Washington, D.C.
Save the Date: https://mosaic-nash.tmacademy.org/

08/06/2026

At ECO 2026, the accepted symposium presented by the Alliance explores a shift toward more integrated thinking in obesity-related HFpEF, where cardiometabolic interactions increasingly define both disease progression and therapeutic response.

From Guidelines to Person-Centred Integrated Care: Improving Outcomes for patients living with or at risk of obesity-related HFpEF reflects the growing recognition that heart failure phenotypes cannot be managed in isolation, particularly as obesity continues to shape risk trajectories across the cardiometabolic spectrum. The discussion highlights the need for care models that move beyond guideline application alone, toward more personalised, integrated approaches in routine clinical practice.

e-SPACE Heart Failure 2026 continues this scientific direction, focusing on how evolving evidence can be translated into practical strategies across heart failure phenotypes.

Continue the discussion in October 2026: https://www.tmacademy.org/
23–24 October 2026 | Virtual Congress

05/06/2026

Heart failure care continues to evolve, but the real challenge remains consistent implementation of guideline-directed therapy across the full spectrum of disease.

Updates in Heart Failure 2026 brings this focus to Stockholm this December, convening leading experts to examine how evidence can be translated into practice more effectively and consistently across clinical settings.

Organized by Karolinska Institute, under the guidance of its scientific leadership and chaired by Professor Gianluigi Savarese, the congress continues its commitment to bridging evidence and action in heart failure care.

14–15 December 2026 | Stockholm, Sweden
Registrations are now open: https://heartfailurecongress.tmacademy.org/

30/05/2026

Heart failure evidence is no longer the challenge. The challenge is what happens after the evidence is published.

In real-world practice, clinicians are often faced with complex patients, competing priorities, and gaps between guideline recommendations and what is actually achievable at the bedside. This is where implementation becomes the real determinant of outcomes.

e-SPACE Heart Failure was designed around this gap, focusing on how contemporary heart failure evidence can be translated into practical clinical decisions. Through expert-led discussions, the programme addresses how therapies are initiated, adjusted, and prioritised in patients who rarely fit trial populations.

It is not just about what the guidelines say, but how they are applied when clinical reality is more complex than the evidence tables.

Missed the sessions? The full programme is now available on demand: https://www.espace-hf.org/2025/

27/05/2026

Heart failure is not an isolated cardiac condition. It is a complex, multi-system syndrome that often intersects with renal dysfunction, metabolic disease, and a wide spectrum of patient comorbidities, all of which shape outcomes and treatment pathways.

This is why integrated, guideline-driven education is essential in modern HF care. e-SPACE Heart Failure is a global virtual initiative designed to support clinicians in translating evidence into practice, with a strong focus on real-world management of heart failure alongside renal and metabolic comorbidities.

Through expert-led, practical learning, the programme explores contemporary guideline updates, patient phenotyping, and multidisciplinary approaches that reflect everyday clinical complexity.

On-demand sessions are now available. If you missed it, you can still explore the full experience and expand your HF knowledge via the TMA platform: https://espacehf.tmacademy.org/

Adresse

Picasso Platz 8
Basel
4052

Webseite

https://www.tmacademy.org/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Translational Medicine Academy erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.